Dysmorphological and pharmacological studies in 4q- syndrome

Genetic Counseling

Volumn 22, Issue 2, 2011, Pages 173-185

  Strehle, Eugen Matthias ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

4q deletion syndrome; 4q syndrome; Drug treatment; Dysmorphology; Food supplement; Pharmacology; Therapy

Indexed keywords

CARNITINE; GROWTH HORMONE; MELATONIN; MULTIVITAMIN; OMEGA 3 FATTY ACID; PLANT EXTRACT; PRESCRIPTION DRUG; PROBIOTIC AGENT; THIOCTIC ACID; UBIDECARENONE;

4Q DELETION SYNDROME; ARTICLE; AUTISM; CHILD; CHROMOSOME 4Q; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CRANIOFACIAL MALFORMATION; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFICACY; DRUG TOLERABILITY; FACE DYSMORPHIA; FEMALE; FOREHEAD; FRUIT; HUMAN; HYPERACTIVITY; INCIDENCE; INTERSTITIAL CHROMOSOME DELETION; MALE; OCCUPATIONAL THERAPY; PATIENT ASSESSMENT; PHENOTYPE; PHYSIOTHERAPY; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SLEEP DISORDER; SPEECH THERAPY; VEGETABLE;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 4; DIETARY SUPPLEMENTS; FACE; FEMALE; HUMANS; INFANT; MALE; PARENTS; PRESCRIPTION DRUGS; PSYCHOTHERAPY; QUESTIONNAIRES; REGISTRIES; TREATMENT OUTCOME;

EID: 79960749405     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. ALDRED M.A., SANFORD R.O., THOMAS N.S., BARROW M.A., WILSON L.C., BRUETON L.A., BONAGLIA M.C., HENNEKAM R.C., ENG C., DENNIS N.R., TREMBATH R.C.: Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes. J. Med. Genet., 2004, 41, 433-439.
2. BENDAVID C., PASQUIER L., WATRIN T., MORCEL K., LUCAS J., GICQUEL I., DUBOURG C., HENRY C., DAVID V., ODENT S., LEVEQUE J., PELLERIN I., GUERRIER D.: Phenotyic variability of a 4q34→ qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother. Eur. J Med. Genet., 2007, 50, 66-72.
3. BONAKDAR R.A., GUARNERI E.: Coenzyme Q10. Am. Fam. Physician, 2005, 72, 1065-1070.
4. BROWN S.L., KOLOZSVARY A., LIU J., JENROW K.A., RYU S., KIM J.H.: Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat. Res., 2010, 173, 462-468.
5. DESHPANDE G., RAO S., PATOLE S., BULSARA M.: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics, 2010, 125, 921-930.
6. DOUGUS T.S., MUTSVANGWA T.E.: A review of facial image analysis for delineation of the facial phenotype associated with fetal alcohol syndrome. Am. J Med. Genet. A, 2010, 152A, 528-536.
7. ELLIS J.M, TAN H.K, GILBERT R.E., MULLER D.P., HENLEY W., MOY R., PUMPHREY R., ANI C., DAVIES S., EDWARDS V., GREEN H., SALT A., LOGAN S.: Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial. BMJ, 2008, 336, 594-597.
8. GHIBU S., RICHARD C., VERGELY C., ZELLER M., COTTIN Y., ROCHETTE L.: Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J. Cardiovasc. Pharmacol., 2009, 54, 391-398.
9. GOLDFRANK D., SCHOENBERGER E., GILBERT F.: Disease genes and chromosomes: disease maps of the human genome. Chromosome 4. Genet. Test., 2003, 7, 351-372.
10. GUANDALINI S.: Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev. Clin. Immunol., 2010, 6, 47-54.
11. GUSTAFSSON P.A., BIRBERG-THORNBERG U., DUCHEN K., LANDGREN M., MALMBERG K., PELLING H., STRANDVIK B., KARLSSON T.: EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr., 2010, 99, 1540-1549.
12. HAMMOND P.: The use of 3D face shape modelling in dysmorphology. Arch. Dis. Child., 2007, 92, 1120-1126.
13. HARRIS W.: Omega-6 and omega-3 fatty acids: partners in prevention. Curr. Opin. Clin. Nutr. Metab. Care, 2010, 13, 125-129.
14. HERBERT M.R., D.A. ZIEGLER D.A., DEUTSCH C.K., L.M. O'BRIEN L.M., KENNEDY D.N., FILIPEK P.A., BAKARDJIEV A.I., HODGSON J., TAKEOKA M., MAKRIS N., CAVINESS V.S.: Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain, 2005, 128, 213-226.
15. HILLIER L.W., GRAVES T.A., FULTON R.S., FULTON L.A., PEPIN K.H., MINX P., WAGNER-MCPHERSON C., LAYMAND., WYLIE K., SEKHON M., BECKER M.C., FEWELL G.A., DELEHAUNTY K.D., MILNER T.L., NASH W.E., KREMITZKI C., ODDY L., DU H., SUN H., BRADSHAW-CORDUM H., ALI J., CARTER J., CORDES M., HARRIS A., ISAK A., VAN BRUNT A., NGUYEN C., DU F., COURTNEY L., KALICKI J., OZERSKY P., ABBOTT S., ARMSTRONG J., BELTER E.A., CARUSO L., CEDRONI M., COTTON M., DAVIDSON T., DESAI A., ELLIOTT G., ERB T., FRONICK C., GAIGE T., HAAKENSON W., HAGLUND K., HOLMES A., HARKINS R., KIM K., KRUCHOWSKI S.S., STRONG C.M., GREWAL N.N., GOYEA E., HOU S., LEVY A., MARTINKA S., MEAD K., MCLELLAN M.D., MEYER R., RANDALL-MAHER J., TOMINSON C., DAUPHIN-KOHLBERG S., KOZLOWICZ-REIUY A., SHAH N., SWEARENGEN-SHAHID S., SNIDER J., STRONG J.T., THOMPSON J., YOAKUM M., LEONARD S., PEARMAN C., TRANI L., RADIONENKO M., WALIGORSKI J.E., WANG C., ROCK S.M., TIN-WOLLAM A.M., MAUPIN R., UTREILLE P., WENDL M.C., YANG S.P., POHL C., WALLIS J.W., SPIETH J., BIERI T.A., BERKOWICZ N., NELSON J.O., OSBORNE J., DING L., MEYER R., SABO A., SHOTLAND Y., SINHA P., WOHLDMANN P.E., COOK L.L., HICKENBOT-HAM M.T., ELDRED J., WILLIAMS D., JONES T.A., SHE X., CICCARELLI F.D., IZAURRALDE E., TAYLOR J., SCHMUTZ J., MYERS R.M., COX D.R., HUANG X., MCPHERSON J.D., MARDIS E.R., CLIFTON S.W., WARREN W.C., CHINWALLA A.T., EDDY S.R., MARRA M.A., OVCHARENKO I., FUREY T.S., MILLER W., EICHLER E.E., BORK P., SUYAMA M., TORRENTS D., WATERSTON R.H., WILSON R.K.: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature, 2005, 434, 724-731.
16. HODGKIN J.: Karyotype, ploidy, and gene dosage. WormBook, 2005, Jun. 25, 1-9. http://www.ncbi.nlm.nih.gov/books/NBK19656/
17. HOLLOX E.J., BARBER J.C., BROOKES A.J., ARMOUR J.A.: Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res., 2008, 18, 1686-1697.
18. HORVATH R., GORMAN G., CHINNERY P.F.: How can we treat mitochondrial encephalopathies? Approaches to therapy. Neurotherapeutics, 2008, 5, 558-568.
19. KELNAR C.J.: The evidence base for growth hormone effectiveness in children. Endocr. Dev., 2010, 18, 23-39.
20. KITSIOU-TZELI S., SISMANI C., KOUMBARIS G., IOANNIDES M., KANAVAKIS E., KOLIALEXI A., MAVROU A., TOULIATOU V., PATSALIS P.C.: Distal del(4) (q33) syndrome: detailed clinical presentation and molecular description with array-CGH. Eur. J. Med. Genet., 2008, 51, 61-67.
21. KOCHARIAN A., SHABANIAN R., RAFIEI-KHORGAMI M., KIANI A., HEIDARI BATENI G.: Cardiol. Young, 2009, 19, 501-506.
22. LAINHART J.E., BIGLER E.D., BOCIAN M., COON H., DINH E., DAWSON G., DEUTSCH C.K., DUNN M., ESTES A., TAGER-FLUSBERG H., FOLSTEIN S., HEPBURN S., HYMAN S., MCMAHON W., MINSHEW N., MUNSON J., OSANN K., OZONOFF S., RODIER P., ROGERS S., SIGMAN M., SPENCE M.A., STODGELL C.J., VOLKMAR F.: Head circumference and height in autism: a study by the Collaborative Program of Excellence in Autism. Am. J. Med. Genet. A, 2006, 140, 2257-2274.
23. LANGILLE R.M., HALL B.K.: Developmental processes, developmental sequences and early vertebrate phylogeny. Biol. Rev. Camb. Philos. Soc., 1989, 64, 73-91.
24. LIONETTI E., INDRIO F., PAVONE L., BORRELLI G., CAVALLO L., FRANCAVILLA R.: Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter, 2010, 15, 79-87.
25. LOMAX A.R., CALDER P.C.: Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr. Pharm. Des., 2009, 15, 1428-1518.
26. MARKIEWICZ M.R., VERSCHUEREN D., ASSAEL L.: Chromosome 4q deletion syndrome: craniofacial characteristics associated with monosomy of the long arm of chromosome 4q. Cleft Palate Craniofac. J., 2010, 47, 518-522.
27. MULLIS P.E., TONELU P.: Regulation of fetal growth: consequences and impact of being born small. Best Pract. Res. Clin. Endocrinol. Metab., 2008, 22, 173-190.
28. NASSER M., JAVAHERI H., FEDOROWICZ Z., NOORANI Z.: Carnitine supplementation for inborn errors of metabolism. Cochrane Database Syst. Rev., 2009 Apr 15, CD006659.
29. QUADRELLI R., STREHLE E.M., VAGLIO A., LARRANDABURU M., MECHOSO B., QUADRELLI A., FAN Y.S., HUANG T.: A girl with del(4)(q33) and occipital encephalocele: clinical description and molecular genetic characterization of a rare patient. Genet. Test., 2007, 11, 4-10.
30. RACHIDI M., LOPES C.: Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome. Am. J. Intellect. Dev. Disabil., 2010, 115, 83-112.
31. REARDON W.: The Bedside Dysmorphologist. Classic Clinical Signs in Human Malformation Syndromes and their Diagnostic Significance. Oxford, University Press, 2008.
32. ROSENFELD R.G.: The future of research into growth hormone responsiveness. Horm. Res., 2009, 71, 71-74.
33. ROSSI M.R., DIMAIO M.S., XIANG B., LU K., KAYMAKCALAN H., SEASHORE M., MAHONEY M.J., LI P.: Clinical and genomic characterization of distal duplications and deletions of chromosome 4q: study of two cases and review of the literature. Am. J Med. Genet. A, 2009, 149A, 2788-2794.
34. ROSSIGNOL D.A.: Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann. Clin. Psychiatry, 2009, 21, 213-236.
35. RUBIO-ALIAGA I., PRZEMCK G.K., FUCHS H., GAILUS-DURNER V., ADLER T., HANS W., HORSCH M., RATHKOLB P., ROZMAN J., SCHREWE A., WAGNER S., HOELTER S.M., BECKER L., KLOPSTOCK T., WURST W., WOLF E., KLINGENSPOR M., IVANDIC B.T., BUSCH D.H., BECKERS J., HRABE DE ANGELIS M.: DIII haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes. PLoS One, 2009, 4, e6054.
36. RUSSELL Z., KONTOPOULOS E.V., QUINTERO R.A., DEBAUCHE D.M., RANELLS J.D.: Prenatal diagnosis of a 4q33-4qter deletion in a fetus with hydrops. Fetal Diagn. Ther., 2008, 24, 250-253.
37. RYAN A.S., ASTWOOD J.D., GAUTIER S., KURATKO C.N., NELSON E.B., SALEM N.: Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prostaglandins Leukot. Essent. Fatty Acids, 2010, 82, 305-314.
38. SENSI A., PRONTERA P., BULDRINI B., PALMA S., AIELLO V., GRUPPIONI E., CALZOURI E., VOLINIA S., MARTINI A.: Cytogenetic and array CGH characterization of an intrachromosomal complex rearrangement of 4q in a patient with a 4q-phenotype. Am. J Med. Genet. A, 2008, 146A, 110-115.
39. SMITH M.: Mental Retardation and Developmental Delay. Genetic and Epigenetic Factors. Oxford, University Press, 2006.
40. STEPHENS F.B., CONSTANTIN-TEODOSIOU D., GREENHAFF P.L.: New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J. Physiol., 2007, 581, 431-444.
41. STEWART D.R.., KLEEFSTRA T.: The chromosome 9q subtelomere deletion syndrome, Am. J. Med. Genet. C Semin. Med. Genet., 2007, 145C, 383-392.
42. STREHLE E.M., BANTOCK H.M.: The phenotype of patients with 4q-syndrome. Genet. Couns., 2003, 14, 195-205.
43. STREHLE E.M., MIDDLEMSS P.M.: Children with 4q-syndrome: the parents' perspective. Genet. Couns., 2007, 18, 189-199.
44. SWERDLOW A.J., SCHOEMAKER M.J., HIGGINS C.D., WRIGHT A.F., JACOBS P.A., UK CLINICAL GENETCS GROUP: Mortality risks in patients with constitutional autosomal chromosome deletions in Britain: a cohort study. Hum. Genet., 2008, 123, 215-224.
45. UTINE G.E., AKTAS D.: Mosaicism for terminal deletion 4q. Genet. Couns., 2006, 17, 205-209.
46. WALTER J.H: L-carnitine. Arch. Dis. Child., 1996, 74, 475-478.